March 3 (Reuters) - Johnson & Johnson (NYSE:JNJ) JNJ.N said on Friday that a state court jury in Missouri had returned a verdict in its favor in the fourth trial to arise out of thousands of lawsuits alleging the company's talc-based products can increase the risk of ovarian cancer.
The jury sided with Johnson & Johnson in a lawsuit by Tennessee resident Nora Daniels, who alleged that she used J&J Baby Powder for 36 years and was diagnosed with ovarian cancer in 2013.
The verdict came after three straight prior jury verdicts in St. Louis against J&J awarding plaintiffs $195 million. More than 2,500 lawsuits are pending in state court in St. Louis.